Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
4.100
-0.010 (-0.24%)
May 14, 2025, 9:30 AM - Market open
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $193.62 million as of May 14, 2025. Its market cap has decreased by -80.79% in one year.
Market Cap
193.62M
Enterprise Value
57.62M
1-Year Change
-80.79%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $193.62M, a decrease of -64.04%. That is a compound annual growth rate of -19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 180.87M | -44.32% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |